August 4, 2025- Cleveland Clinic is now one of eight sites in the Davos Alzheimer’s Collaborative Healthcare System Preparedness (DAC-SP) Accurate Diagnosis project, which aims to develop a pathway for accurate and timely Alzheimer’s disease diagnosis using blood-based biomarkers in primary and specialty care settings.
Cleveland Clinic’s site will focus on implementing blood-based biomarkers as part of new patient visits at the Center for Geriatric Medicine, with support from the Lou Ruvo Center for Brain Health for patients seeking confirmatory testing and novel therapeutics.
The Davos Alzheimer’s Collaborative (DAC) is a worldwide initiative seeking to cure Alzheimer’s disease and improve brain health. The DAC-SP Accurate Diagnosis project represents the first-ever global implementation study to examine biomarker pathology assessments throughout the Alzheimer’s disease and related disorders (ADRD) diagnostic pathway.